Abstract
Tourette syndrome is a childhood-onset neurodevelopmental disorder defined by multiple motor tics and at least one vocal tic persisting for more than a year. Its cognitive interest lies in the tic itself: a movement that is neither fully voluntary nor fully involuntary, but is preceded by a premonitory urge — an uncomfortable sensation that the tic relieves — and can be briefly suppressed at a mounting cost in discomfort. That structure places tics at the boundary of volition and makes the syndrome a natural probe of how the basal ganglia gate action. Tics wax and wane, follow a characteristic rise-and-decline across development, and are usually accompanied by attention and obsessive-compulsive features, so the condition is best understood as a disorder of the circuits that select and inhibit motor programs rather than of movement alone.
Keywords: Tourette syndrome, tic, premonitory urge
Tourette syndrome takes its name from Georges Gilles de la Tourette, who in 1885, working under Charcot at the Salpêtrière, gave the first systematic description of a disorder combining involuntary movements, vocalisations, and echophenomena (Robertson, 2000). For most of the twentieth century it was misclassified as a psychiatric curiosity; the modern account treats it as a highly heritable neurodevelopmental condition of the cortico-striatal circuits that select and suppress movement (Leckman, 2002). What makes it a subject for cognitive psychology, rather than movement neurology alone, is the tic's peculiar phenomenology — a semi-voluntary act driven by an inner urge and modulated by attention, suppression, and stress — together with the near-universal company of attentional and obsessive-compulsive symptoms (Robertson et al., 2017).
Key Takeaways
- Tourette syndrome is defined by multiple motor tics plus at least one vocal tic, both present for more than a year, with onset before age 18.
- Tics are semi-voluntary: most are preceded by a premonitory urge that the tic relieves, and can be briefly suppressed at a rising cost in discomfort.
- The disorder localises to the cortico-striato-thalamo-cortical circuits, where a failure to inhibit unwanted motor programs releases the tic.
- Tics wax and wane and follow a developmental arc: onset around age 5–7, worst severity around 10–12, and substantial decline for most by early adulthood.
- Comorbidity is the rule, not the exception: attention-deficit/hyperactivity disorder and obsessive-compulsive disorder each affect roughly half of patients.
Figure 1
The Tic Cycle and the Cortico-Striatal Circuit That Gates It
What Tourette Syndrome Is
Tourette syndrome is a neurodevelopmental disorder defined by tics: sudden, rapid, recurrent, non-rhythmic movements and vocalisations. The diagnostic criteria require multiple motor tics and at least one vocal (phonic) tic, both present at some time during the illness though not necessarily concurrently, persisting for more than one year, with onset before the age of 18 (Robertson et al., 2017); diagnosis is clinical, resting on the history and observation of tics rather than on any laboratory test, and European consensus guidelines set out how that assessment should proceed (Cath et al., 2011). In the MeSH and neurological classifications the condition sits within the family of *tic disorders* and, more broadly, among the *basal ganglia diseases*, reflecting where its pathology is thought to lie (Singer, 2005). It is far more common than its dramatic media image suggests — coprolalia, the involuntary uttering of obscenities, occurs in only a small minority — and most cases are mild enough to go undiagnosed (Robertson, 2000).
Tics are distinguished from other abnormal movements by their character and their context. Unlike the rhythmic tremor of Parkinson's or the flowing, dance-like movements of chorea, a tic is brief, stereotyped, and repeatable on demand; it can be mimicked, briefly held back, and is often experienced as something the person *does* in response to an urge rather than something that simply happens to them (Jankovic, 2001). Simple tics involve a single muscle group — an eye blink, a head jerk, a sniff, a throat-clear — while complex tics are coordinated sequences that can resemble purposeful acts, such as touching, jumping, or echoing another's words (echolalia). This semi-voluntary quality is the feature that pulls Tourette syndrome into cognitive psychology: the tic lives on the border between action and reflex (Ganos, 2016).
Comorbidity is so common that a pure tic disorder is the exception. In the largest genetic-epidemiological sample assembled, roughly 86% of individuals with Tourette syndrome met criteria for at least one other psychiatric disorder over their lifetime, with attention-deficit/hyperactivity disorder and obsessive-compulsive disorder each present in about half (Hirschtritt et al., 2015). Table 1 sets out the core features that define the syndrome and separate it from the movement and psychiatric conditions it can resemble.
Table 1
Tics in Tourette Syndrome Distinguished From Other Abnormal Movements
| Feature | Tic (Tourette syndrome) | Chorea | Compulsion (OCD) |
|---|---|---|---|
| Preceded by an urge | Yes, a premonitory urge | No | Yes, driven by an obsession |
| Suppressible | Briefly, at rising discomfort | No | Resisted with anxiety |
| Form of movement | Brief, stereotyped, repeatable | Flowing, random, non-repeating | Elaborate, goal-directed ritual |
| Course over time | Waxes and wanes; declines with age | Progressive in many causes | Chronic, often stable |
| Typical onset | Childhood (age 5–7) | Any age, cause-dependent | Childhood to early adulthood |
The Premonitory Urge
The single most important cognitive fact about tics is that most are not experienced as purely involuntary. Older children and adults report that a tic is preceded by a premonitory urge: a localised, uncomfortable sensation — a build-up of tension, an itch, a feeling of something being not-quite-right — that mounts until the tic is performed, whereupon it is relieved (Leckman et al., 1993). In the original survey that established the phenomenon, the great majority of patients described such sensations, most often in the hands, shoulders, throat, and midline of the face, and most reported that the tic was carried out to discharge the urge rather than arising out of nowhere (Leckman et al., 1993).
Demo 1 — The premonitory-urge cycle
A tic is the motor half of a loop: an inner urge builds and the tic relieves it. Choose how long to hold the tic back and watch the urge climb, the tic fire at release, and the rebound that follows a long suppression.
This reframes the tic as the motor half of a sensorimotor cycle. The urge makes the tic *semi-voluntary*: the movement is a response to an internal signal, and like other responses it can be withheld — but only for a while, and only at a cost. Patients can suppress tics for seconds to minutes, particularly when they must (in a meeting, during an examination), but suppression is effortful, the urge grows during it, and there is often a rebound flurry of tics once vigilance relaxes (Cavanna, 2017). The premonitory urge is now understood as central to the disorder's phenomenology and to its treatment: the leading behavioural therapy, habit-reversal training within comprehensive behavioural intervention, teaches patients to detect the urge and deploy a competing response, turning an implicit sensorimotor loop into an explicit, controllable one (Cavanna, 2017). The urge also links Tourette syndrome to obsessive-compulsive disorder, where an analogous inner pressure drives a relieving act, and may explain why the two conditions so often co-occur (Ganos, 2016).
The Cortico-Striatal Loop
Where does a tic come from? The dominant account places it in the cortico-striato-thalamo-cortical (CSTC) circuits — the loops through which the cortex, via the basal ganglia and thalamus, selects which motor programs to run and suppresses the rest (Mink, 2001). In the healthy circuit, the striatum's inhibitory output holds unwanted movements in check by keeping the basal ganglia's output nuclei tonically active; releasing a specific movement requires briefly and focally lifting that inhibition. Mink's influential model proposes that in Tourette syndrome a small population of striatal neurons becomes aberrantly active, producing a *focal loss of inhibition* that opens the gate to a single unwanted motor program — the tic — while the surrounding programs stay suppressed (Mink, 2001).
Demo 2 — The cortico-striatal gate
The striatum holds unwanted movements in check; releasing one means focally lifting its inhibition. In Tourette syndrome an overactive striatal focus lifts inhibition on an unwanted program — the tic — while the rest stay suppressed. Toggle the circuit and pick the movement you intend.
Structural and functional imaging supports a basal-ganglia locus. Volumetric studies find the caudate nucleus to be smaller in Tourette syndrome, and a smaller childhood caudate predicts more severe tics in adulthood, implicating the striatum in both the presence and the persistence of the disorder (Peterson et al., 2001). The circuit framing also accommodates the disorder's other features: the same loops carry the limbic and associative territories that, when analogously dysregulated, could generate the obsessive-compulsive and attentional symptoms that so often accompany the motor tics, so a single circuit-level fault expresses itself across motor, cognitive, and affective channels (Singer, 2005). Contemporary syntheses retain this architecture while adding detail about the dopaminergic and other neuromodulatory signals that set the gain of the striatal gate, and deep brain stimulation of nodes within these loops has become a treatment of last resort for severe, refractory tics — a direct demonstration that the circuit is causal (Johnson et al., 2023).
The Tic Trajectory
Tics are not static. Over short timescales they wax and wane, fluctuating in frequency and intensity from week to week and shifting in bodily location and form, so that an eye-blinking tic may give way to a head jerk and then to a vocalisation over months (Leckman, 2002). Over the long timescale of development they trace a characteristic arc. Tics typically begin around age five to seven, most often as simple motor tics of the face and head; they worsen through later childhood to a peak in severity around age ten to twelve; and then, in the great majority, they decline through adolescence (Bloch & Leckman, 2009).
Demo 3 — The developmental tic trajectory
Tics begin in childhood, peak around age 10–12, and decline through the teens. Set an age to read off expected tic severity (gold) and the modelled chance of substantial remission since the peak (blue), using the constant-hazard model from the worked example.
This developmental course is one of the most clinically important facts about the syndrome, because it governs prognosis. In the follow-up literature, by early adulthood roughly a third of patients are essentially tic-free, another third have tics that are much reduced, and the remaining third continue to have clinically significant tics — so for most children the worst is over by the late teens (Bloch & Leckman, 2009). Adult tic severity is only weakly predicted by childhood severity, but a smaller childhood caudate volume is associated with worse adult outcomes, tying the trajectory back to the basal-ganglia circuit (Peterson et al., 2001). The waxing-and-waning also has a practical consequence for evaluating treatments: because tics fluctuate and tend to improve over time on their own, any intervention must be judged against that moving, generally improving baseline, which is why controlled trials are essential in this disorder (Pringsheim et al., 2019).
Worked Example
The reassuring developmental decline of tics can be made quantitative with a simple constant-hazard model of remission, in the same spirit that survival analysis treats time-to-event data. This turns the qualitative observation that most improve by early adulthood into numbers a clinician can use.
Take the peak of tic severity to fall at about age 10.6, as reported in the natural-history literature (Bloch & Leckman, 2009). Model substantial tic remission as a process with a constant annual hazard $h$: in each year after the peak, a patient not yet substantially improved has probability $h$ of crossing into substantial improvement. Then the probability of having substantially improved within $n$ years of the peak is:
$$P(\text{improved within } n \text{ years}) = 1 - (1-h)^n$$
We can fix $h$ from the reported outcome that roughly two-thirds of patients are much improved or tic-free by about age 18 — that is, about $n = 7.4$ years after the peak:
$$1 - (1-h)^{7.4} = 0.67 \;\Rightarrow\; (1-h)^{7.4} = 0.33 \;\Rightarrow\; 1-h = 0.33^{1/7.4} \approx 0.861$$
So the fitted annual remission hazard is $h \approx 0.14$, about 14% per year. The same formula then projects the whole trajectory:
$$P(5 \text{ years, age } \approx 15.6) = 1 - (0.861)^5 = 1 - 0.473 = 0.527 \approx 53\%$$
$$P(7.4 \text{ years, age } \approx 18) = 1 - (0.861)^{7.4} = 1 - 0.330 = 0.670 \approx 67\%$$
$$P(10 \text{ years, age } \approx 20.6) = 1 - (0.861)^{10} = 1 - 0.223 = 0.777 \approx 78\%$$
The model is an idealisation — real remission is not literally memoryless, and the notion of substantial improvement is only a threshold on a continuous severity that itself waxes and wanes — but it captures the clinically essential shape: improvement accumulates steadily after the peak, so that by the early twenties roughly three-quarters of patients have crossed into substantial improvement (Bloch & Leckman, 2009). It also frames why controlled trials matter: an uncontrolled treatment begun near the peak will appear effective simply because it rides this rising remission curve, and only a comparison group reveals the drug or therapy's true added effect (Pringsheim et al., 2019).
Discussion
The scientific interest of Tourette syndrome for cognitive psychology is that it makes the machinery of action selection visible by breaking it in a specific, informative way. Ordinarily the process by which the brain chooses one motor program and suppresses its competitors is silent and automatic; in Tourette syndrome a fragment of that process escapes into behaviour as a tic, and — crucially — the person can feel it coming and can, for a time, hold it back (Mink, 2001). The three demonstrations on this page track three faces of the disorder: the premonitory-urge cycle shows the tic as a sensorimotor loop, the cortico-striatal schematic shows the circuit whose focal disinhibition releases it, and the trajectory curve shows how the whole pattern rises and falls across development.
The convergence across these levels is the strength of the modern account. A clinician timing a patient's suppression against a mounting urge, a neuroanatomist measuring a smaller caudate, and a physiologist modelling a focal loss of striatal inhibition are describing one phenomenon at three resolutions (Leckman, 2002). Genetics has begun to supply the missing bottom layer: Tourette syndrome is highly heritable and polygenic, and the first genome-wide studies have identified common variants of small effect and implicated genes expressed in exactly the cortico-striatal circuits the physiology points to (Yu et al., 2019). Where the account remains incomplete is in linking the levels tightly enough to predict an individual's course, and in explaining why the same circuit fault so reliably brings attentional and obsessive-compulsive symptoms with it — the comorbidity is a clue to shared circuitry that is not yet fully read (Hirschtritt et al., 2015).
Cognitive Implications
For cognitive psychology, Tourette syndrome is a natural experiment on the voluntary control of action. The classic dichotomy between voluntary and involuntary movement turns out to be too coarse: the tic occupies a genuine middle ground, generated internally like a voluntary act, felt as compelled like a reflex, and modulated by the same top-down inhibitory control that governs deliberate behaviour (Ganos, 2016). Studies of tic suppression thus become studies of inhibition itself: they show that a prepotent, urge-driven motor tendency can be held in check by executive effort, that the effort is metabolically and attentionally costly, and that the suppressed tendency rebounds — a pattern with clear parallels to the suppression of other unwanted responses (Cavanna, 2017).
The syndrome also illuminates the relationship between the basal ganglia and habit. The cortico-striatal loops implicated in tics are the same circuits that support procedural learning and the formation of habits — the gradual conversion of deliberate action into automatic routine (Mink, 2001). A tic can be read as a maladaptive intrusion into this system: a fragment of motor output that has become abnormally easy to release, an over-learned micro-habit triggered by an internal cue. That framing connects Tourette syndrome to the broader psychology of automaticity and to the observation that its most effective behavioural treatment works precisely by building a competing habit, and it clarifies why attention to the urge is the therapeutic lever: making an automatic loop explicit is what allows it to be controlled (Cavanna, 2017).
Current Directions
Contemporary Tourette research is moving on several fronts at once. Genetics is the most active: after decades in which twin and family studies established high heritability without naming a gene, genome-wide association studies of large international samples have begun to identify common risk variants and to show that Tourette syndrome shares genetic architecture with obsessive-compulsive disorder and other neuropsychiatric conditions, giving the clinical comorbidity a molecular footing (Yu et al., 2019).
A second front is treatment. Evidence-based guidelines now rank behavioural therapy — comprehensive behavioural intervention for tics, built on habit reversal — alongside pharmacotherapy as a first-line option, a shift that follows directly from the cognitive understanding of the premonitory urge (Pringsheim et al., 2019). For the small minority with severe, treatment-refractory tics, deep brain stimulation of targets within the cortico-striatal loops has moved from case reports toward controlled evaluation, and the accumulating results are refining which node and which stimulation parameters best interrupt tics while sparing normal movement (Johnson et al., 2023). Across genetics, behavioural therapy, and neuromodulation the unifying question is the one the Discussion raised — how a single circuit fault produces such a variable, comorbid, and self-remitting picture — and progress on it will decide whether the disorder is best treated at the level of genes, circuits, or the sensorimotor loop the patient actually experiences (Robertson et al., 2017).
Common Misconceptions
- Everyone with Tourette syndrome swears involuntarily.
- No. Coprolalia — the involuntary uttering of obscenities — is the most famous feature but one of the rarest, affecting only a small minority of patients. Most tics are simple movements and sounds such as blinking, head jerks, sniffing, and throat-clearing (Robertson, 2000).
- Tics are entirely involuntary.
- Not quite. Most tics are preceded by a premonitory urge and are better described as semi-voluntary: they can be briefly suppressed, at a mounting cost in discomfort, and are performed to relieve the urge (Leckman et al., 1993).
- It is a psychological or emotional problem caused by bad parenting.
- No. Tourette syndrome is a highly heritable neurodevelopmental disorder of the cortico-striatal circuits; stress can worsen tics, but it does not cause the condition (Yu et al., 2019).
- Children do not grow out of it.
- Most improve substantially. Tics typically peak around age ten to twelve and then decline, so that by early adulthood roughly two-thirds of patients are tic-free or much improved (Bloch & Leckman, 2009).
Glossary
- Basal ganglia.
- A group of subcortical nuclei, including the striatum, that select and suppress motor programs; the site of the circuit dysfunction in Tourette syndrome.
- Caudate nucleus.
- Part of the striatum; found smaller in Tourette syndrome, and a smaller childhood caudate predicts more severe tics in adulthood.
- Chorea.
- A movement disorder of flowing, random, non-repeating movements; distinguished from tics, which are brief, stereotyped, and repeatable.
- Comorbidity.
- The co-occurrence of additional disorders; in Tourette syndrome, attention-deficit/hyperactivity disorder and obsessive-compulsive disorder are the most common.
- Coprolalia.
- The involuntary utterance of obscene or socially unacceptable words; a dramatic but uncommon complex vocal tic present in only a minority of patients.
- Cortico-striato-thalamo-cortical (CSTC) circuit.
- The looping pathway from cortex through the basal ganglia and thalamus and back, which gates movement; its focal disinhibition is thought to release tics.
- Deep brain stimulation.
- Electrical stimulation of a node within the cortico-striatal loops; a treatment of last resort for severe, refractory tics that demonstrates the circuit is causal.
- Echolalia.
- The involuntary repetition of another person's words; a complex vocal tic that formed part of the syndrome's original description.
- Habit-reversal training.
- A behavioural therapy that teaches patients to detect the premonitory urge and perform a competing response, the core of comprehensive behavioural intervention for tics.
- Premonitory urge.
- The uncomfortable sensation that precedes a tic and is relieved by performing it, making the tic a semi-voluntary response to an internal signal.
- Striatum.
- The input structure of the basal ganglia (caudate and putamen); a focal loss of its inhibitory output is proposed to open the gate to an unwanted motor program.
- Tic.
- A sudden, rapid, recurrent, non-rhythmic movement (motor tic) or vocalisation (vocal tic); brief, stereotyped, and repeatable, distinguishing it from chorea or tremor.
- Tourette syndrome.
- A neurodevelopmental disorder defined by multiple motor tics plus at least one vocal tic persisting more than a year, with childhood onset.
- Waxing and waning.
- The characteristic fluctuation of tics in frequency, intensity, and location over weeks to months, on top of the longer developmental rise and decline.
Key Researchers
Christos Ganos
Movement-disorders neurologist at the University of Toronto and the Charité in Berlin, whose work addresses the pathophysiology of tics and the mechanisms of voluntary tic control. ORCID - Google Scholar
Joseph Jankovic
Professor of Neurology and Distinguished Chair in Movement Disorders at Baylor College of Medicine, author of the modern clinical synthesis of tics and Tourette syndrome within movement neurology. Faculty Page - Wikipedia
James F. Leckman
Neison Harris Professor of Child Psychiatry and Pediatrics at the Yale Child Study Center, whose work established the premonitory urge as central to tics and mapped the natural history and comorbidity of the syndrome. ORCID - Faculty Page
Jonathan W. Mink
Frederick A. Horner Distinguished Professor in Pediatric Neurology at the University of Rochester, who proposed the influential focal-disinhibition model of how the basal ganglia release a tic. Profile
Michael S. Okun
Professor and chair of neurology at the University of Florida and director of the Norman Fixel Institute, a leader in the deep brain stimulation of severe, treatment-refractory Tourette syndrome. ORCID - Google Scholar - Wikipedia
Mary M. Robertson
Emeritus Professor of Neuropsychiatry at University College London and co-founder of the European Society for the Study of Tourette Syndrome, whose reviews defined the associated conditions and clinical complexity of the disorder. Faculty Page
Harvey S. Singer
Professor of Neurology and Pediatrics at Johns Hopkins University School of Medicine, whose work traced the path from tic behaviour to the underlying biology of the basal-ganglia circuits. Faculty Page
Frequently Asked Questions
Is Tourette syndrome a psychiatric or a neurological disorder?
Both labels apply, and the boundary is artificial. Tourette syndrome is a neurodevelopmental disorder of the brain circuits that select and suppress movement, so it is neurological in mechanism, but it is managed by psychiatrists and neurologists alike because its tics and its frequent obsessive-compulsive and attentional features span both fields.
Do people with Tourette syndrome swear uncontrollably?
Usually not. Coprolalia, the involuntary uttering of obscenities, is the most publicised feature but affects only a small minority. The typical picture is far milder: simple motor and vocal tics such as blinking, head movements, sniffing, and throat-clearing.
Can tics be controlled?
Partly, and only for a time. Most people can suppress their tics briefly, especially when they need to, but suppression is effortful, the premonitory urge grows during it, and tics often rebound afterward. Behavioural therapy uses this controllability, training patients to substitute a competing response when the urge arises.
What causes Tourette syndrome?
It is highly heritable and polygenic: many common gene variants of small effect, acting on the cortico-striatal circuits, combine to raise risk. It is not caused by parenting or by emotional trauma, though stress and fatigue can make existing tics worse.
Will a child grow out of it?
Most improve substantially. Tics usually peak around age ten to twelve and then decline through adolescence, so that by early adulthood roughly two-thirds of patients are tic-free or much improved, though a minority continue to have significant tics.
What is a premonitory urge?
It is the uncomfortable sensation that precedes most tics: a build-up of tension, an itch, or a feeling of something not being quite right, which performing the tic relieves. Recognising the urge is the basis of the leading behavioural treatment.
How is Tourette syndrome treated?
First-line options are behavioural therapy built on habit reversal and, when needed, medication that dampens the overactive circuit. For the rare, severe, treatment-refractory case, deep brain stimulation of the motor loop is an option. Treatment targets the most impairing symptoms rather than every tic.
Why do the tics keep changing?
Tics wax and wane, shifting in frequency, intensity, and bodily location over weeks and months, on top of the longer developmental rise and fall. This fluctuation is intrinsic to the disorder and is one reason controlled trials are needed to judge whether a treatment truly works.
Support Organizations
Tourette Association of America — national advocacy, education, and support organisation for Tourette syndrome and tic disorders. (United States)
Tourettes Action — patient information, research support, and a helpline for people with Tourette syndrome. (United Kingdom)
National Institute of Neurological Disorders and Stroke (NINDS) — federal source of information on Tourette syndrome and other neurological disorders. (United States)
References
Leckman, J. F., Walker, D. E., & Cohen, D. J. (1993). Premonitory urges in Tourette's syndrome. American Journal of Psychiatry, 150(1), 98–102. https://doi.org/10.1176/ajp.150.1.98
Robertson, M. M. (2000). Tourette syndrome, associated conditions and the complexities of treatment. Brain, 123(3), 425–462. https://doi.org/10.1093/brain/123.3.425
Jankovic, J. (2001). Tourette's syndrome. New England Journal of Medicine, 345(16), 1184–1192. https://doi.org/10.1056/NEJMra010032
Mink, J. W. (2001). Basal ganglia dysfunction in Tourette's syndrome: A new hypothesis. Pediatric Neurology, 25(3), 190–198. https://doi.org/10.1016/S0887-8994(01)00262-4
Peterson, B. S., Staib, L., Scahill, L., Zhang, H., Anderson, C., Leckman, J. F., Cohen, D. J., Gore, J. C., Albert, J., & Webster, R. (2001). Regional brain and ventricular volumes in Tourette syndrome. Archives of General Psychiatry, 58(5), 427–440. https://doi.org/10.1001/archpsyc.58.5.427
Leckman, J. F. (2002). Tourette's syndrome. The Lancet, 360(9345), 1577–1586. https://doi.org/10.1016/S0140-6736(02)11526-1
Singer, H. S. (2005). Tourette's syndrome: From behaviour to biology. The Lancet Neurology, 4(3), 149–159. https://doi.org/10.1016/S1474-4422(05)01012-4
Bloch, M. H., & Leckman, J. F. (2009). Clinical course of Tourette syndrome. Journal of Psychosomatic Research, 67(6), 497–501. https://doi.org/10.1016/j.jpsychores.2009.09.002
Cath, D. C., Hedderly, T., Ludolph, A. G., Stern, J. S., Murphy, T., Hartmann, A., Czernecki, V., Robertson, M. M., Martino, D., Münchau, A., & Rizzo, R. (2011). European clinical guidelines for Tourette syndrome and other tic disorders. Part I: Assessment. European Child & Adolescent Psychiatry, 20(4), 155–171. https://doi.org/10.1007/s00787-011-0164-6
Hirschtritt, M. E., Lee, P. C., Pauls, D. L., Dion, Y., Grados, M. A., Illmann, C., King, R. A., Sandor, P., McMahon, W. M., Lyon, G. J., Cath, D. C., Kurlan, R., Robertson, M. M., Osiecki, L., Scharf, J. M., & Mathews, C. A. (2015). Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry, 72(4), 325–333. https://doi.org/10.1001/jamapsychiatry.2014.2650
Ganos, C. (2016). Tics and Tourette's: Update on pathophysiology and tic control. Current Opinion in Neurology, 29(4), 513–518. https://doi.org/10.1097/WCO.0000000000000356
Cavanna, A. E. (2017). Neurobiology of the premonitory urge in Tourette's syndrome: Pathophysiology and treatment implications. The Journal of Neuropsychiatry and Clinical Neurosciences, 29(4), 412–419. https://doi.org/10.1176/appi.neuropsych.16070141
Robertson, M. M., Eapen, V., Singer, H. S., Martino, D., Scharf, J. M., Paschou, P., Roessner, V., Woods, D. W., Hariz, M., Mathews, C. A., Črnčec, R., & Leckman, J. F. (2017). Gilles de la Tourette syndrome. Nature Reviews Disease Primers, 3, 16097. https://doi.org/10.1038/nrdp.2016.97
Yu, D., Sul, J. H., Tsetsos, F., Nawaz, M. S., Huang, A. Y., Zelaya, I., Illmann, C., Osiecki, L., Darrow, S. M., Hirschtritt, M. E., et al. (2019). Interrogating the genetic determinants of Tourette's syndrome and other tic disorders through genome-wide association studies. American Journal of Psychiatry, 176(3), 217–227. https://doi.org/10.1176/appi.ajp.2018.18070857
Pringsheim, T., Okun, M. S., Müller-Vahl, K., Martino, D., Jankovic, J., Cavanna, A. E., Woods, D. W., Robinson, M., Jarvie, E., Roessner, V., Oskoui, M., Holler-Managan, Y., & Piacentini, J. (2019). Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology, 92(19), 896–906. https://doi.org/10.1212/WNL.0000000000007466
Johnson, K. A., Worbe, Y., Foote, K. D., Butson, C. R., Gunduz, A., & Okun, M. S. (2023). Tourette syndrome: Clinical features, pathophysiology, and treatment. The Lancet Neurology, 22(2), 147–158. https://doi.org/10.1016/S1474-4422(22)00303-9